Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

被引:477
|
作者
Mandelblatt, Jeanne S. [1 ]
Cronin, Kathleen A.
Bailey, Stephanie
Berry, Donald A.
de Koning, Harry J.
Draisma, Gerrit
Huang, Hui
Lee, Sandra J.
Munsell, Mark
Plevritis, Sylvia K.
Ravdin, Peter
Schechter, Clyde B.
Sigal, Bronislava
Stoto, Michael A.
Stout, Natasha K.
van Ravesteyn, Nicolien T.
Venier, John
Zelen, Marvin
Feuer, Eric J.
机构
[1] Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
关键词
CARCINOMA IN-SITU; BREAST-CANCER MORTALITY; UPPER AGE LIMIT; COST-EFFECTIVENESS; FOLLOW-UP; WOMEN; OLDER; OVERDIAGNOSIS; OVERTREATMENT; PERFORMANCE;
D O I
10.7326/0003-4819-151-10-200911170-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite trials of mammography and widespread use, optimal screening policy is controversial. Objective: To evaluate U. S. breast cancer screening strategies. Design: 6 models using common data elements. Data Sources: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. Target Population: A contemporary population cohort. Time Horizon: Lifetime. Perspective: Societal. Interventions: 20 screening strategies with varying initiation and cessation ages applied annually or biennially. Outcome Measures: Number of mammograms, reduction in deaths from breast cancer or life-years gained (vs. no screening), false-positive results, unnecessary biopsies, and overdiagnosis. Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. Screening biennially maintained an average of 81% (range across strategies and models, 67% to 99%) of the benefit of annual screening with almost half the number of false-positive results. Screening biennially from ages 50 to 69 years achieved a median 16.5% (range, 15% to 23%) reduction in breast cancer deaths versus no screening. Initiating biennial screening at age 40 years (vs. 50 years) reduced mortality by an additional 3% (range, 1% to 6%), consumed more resources, and yielded more false-positive results. Biennial screening after age 69 years yielded some additional mortality reduction in all models, but overdiagnosis increased most substantially at older ages. Results of Sensitivity Analysis: Varying test sensitivity or treatment patterns did not change conclusions. Limitation: Results do not include morbidity from false-positive results, patient knowledge of earlier diagnosis, or unnecessary treatment. Conclusion: Biennial screening achieves most of the benefit of annual screening with less harm. Decisions about the best strategy depend on program and individual objectives and the weight placed on benefits, harms, and resource considerations.
引用
收藏
页码:738 / W247
页数:15
相关论文
共 50 条
  • [1] Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms (vol 151, pg 738, 2009)
    Mandelblatt, J. S.
    Cronin, K. A.
    Bailey, S.
    Berry, D. A.
    de Koning, H. J.
    Draisma, G.
    Huang, H.
    Lee, S. J.
    Munsell, M.
    Plevritis, S. K.
    Ravdin, P.
    Schechter, C. B.
    Sigal, B.
    Stoto, M. A.
    Stout, N. K.
    van, Ravesteyn N. T.
    Venier, J.
    Zelen, M.
    Feuer, E. J.
    ANNALS OF INTERNAL MEDICINE, 2010, 152 (02) : 136 - 136
  • [2] Benefits and harms of mammography screening
    Hackshaw, Allan
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [3] Benefits and harms of mammography screening
    Magnus Løberg
    Mette Lise Lousdal
    Michael Bretthauer
    Mette Kalager
    Breast Cancer Research, 17
  • [4] Benefits and harms of mammography screening
    Loberg, Magnus
    Lousdal, Mette Lise
    Bretthauer, Michael
    Kalager, Mette
    BREAST CANCER RESEARCH, 2015, 17
  • [5] Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis
    van Ravesteyn, Nicolien T.
    Stout, Natasha K.
    Schechter, Clyde B.
    Heijnsdijk, Eveline A. M.
    Alagoz, Oguzhan
    Trentham-Dietz, Amy
    Mandelblatt, Jeanne S.
    de Koning, Harry J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (07):
  • [6] Discussing the benefits and harms of screening mammography
    Brennan, Meagan
    Houssami, Nehmat
    MATURITAS, 2016, 92 : 150 - 153
  • [7] Quantifying the Benefits and Harms of Screening Mammography
    Welch, H. Gilbert
    Passow, Honor J.
    JAMA INTERNAL MEDICINE, 2014, 174 (03) : 448 - 453
  • [8] Risk Stratification for Screening Mammography: Benefits and Harms
    Lee, Cindy S.
    Sickles, Edward A.
    Moy, Linda
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 212 (02) : 250 - 258
  • [9] Women should be fully informed of the potential benefits and harms before screening mammography - Commentary
    Kerlikowske, K
    WESTERN JOURNAL OF MEDICINE, 2000, 173 (05): : 313 - 314
  • [10] Benefits and Harms of Screening Mammography Frequency by Age and Comorbidity Score
    Braithwaite, D.
    Zhu, W.
    Hubbard, R.
    O'Meara, E. S.
    Miglioretti, D. L.
    Geller, B.
    Dittus, K.
    Wernli, K.
    Moore, D.
    Kerlikowske, K.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (03) : 565 - 565